{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"","title":"CAR T-cells: Insights into a pioneering therapy for cancer on World Cancer Day ","description":"

Sunday the 4th of February marks World Cancer Day - this represents an international effort to raise awareness about cancer and to promote research into cancer treatments. At Kinesis, we hope to contribute this effort by investigating a cutting-edge cellular immunotherapy called Chimeric Antigen Receptor T-cell therapy or 'CAR' T-cell therapy. This episode features an interview with Dr Paul Maciocia who is a Clinical Senior Research Fellow at the UCL Cancer Institute, where he specialises in developing CAR T-cell therapies for cancers of T-cells. Although CAR T-cell therapy has shown remarkable success with treating certain types of cancer, are there any issues that are preventing them from being routinely used in clinic?


References:


https://www.uicc.org/what-we-do/events/world-cancer-leaders-summit

https://www.europarl.europa.eu/RegData/etudes/ATAG/2023/739315/EPRS_ATA(2023)739315_EN.pdf

https://www.who.int/news-room/fact-sheets/detail/cancer

https://ashpublications.org/blood/article/140/1/25/485152/Anti-CCR9-chimeric-antigen-receptor-T-cells-for-T

https://www.england.nhs.uk/2023/04/nhs-to-roll-out-personalised-car-t-cancer-therapies-to-hundreds-more-people/


Directed by Elsa Rogero

Researched by Esther Cheung

Hosted by Casey Teo

Edited by He Ning Seah & Gaya Nair


","author_name":"UCL Kinesis Magazine"}